Early targeted treatment reduces the chance of prolonged thinning
Future research directions Conduct RCT studies to verify its efficacy and safety in diseases such as IBD and gastric ulcers
We are excited to share new insights that may benefit the many women living with obesity. Weight loss and heart health data In a post-hoc analysis of the STEP UP trial, premenopausal women with obesity lost an average of 22.6% of their body weight on once-weekly high-dose Wegovy (semaglutide 7.2 mg) with over 4 in 10 (41.4%) achieving exceptional 25% or more weight loss, compared with placebo
The tiredness is typically mild to moderate, improves with time, and can be managed with proper hydration, nutrition, and a gradual dose escalation
Its about biology, said Saman Rahmanian, co-founder and chief product officer
The timestamp is only as accurate as the clock in the camera, and it may be completely wrong